Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Racagni

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
Journal of Neuroscience Research|May 8, 2000
Apoptosis induced by 2-chloro-adenosine and 2-chloro-2'-deoxy-adenosine in a human astrocytoma cell line: differential mechanisms and possible clinical relevanceS Ceruti, C Franceschi, D Barbieri, et al.
Pharmacological Reviews|June 10, 2018
International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological TargetsF Caraci, F Calabrese, R Molteni, et al.
Journal of Affective Disorders|June 5, 1999
Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistasN Brunello, H Akiskal, P Boyer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 9, 2000
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neurolepticsM Maes, L Bocchio Chiavetto, S Bignotti, et al.
Cardiovascular Diabetology|November 4, 2020
Depression and cardiovascular risk-association among Beck Depression Inventory, PCSK9 levels and insulin resistanceC Macchi, C Favero, A Ceresa, et al.
Molecular Psychiatry|February 19, 2014
Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortexG Treccani, L Musazzi, C Perego, et al.
Neuropsychobiology|October 3, 2000
Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatmentN Brunello, R Armitage, I Feinberg, et al.
The American Journal of Pathology|January 1, 1996
beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's diseaseG Giaccone, B Pedrotti, A Migheli, et al.
Journal of Affective Disorders|August 15, 2000
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatmentN Brunello, J A den Boer, L L Judd, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 7, 1998
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, ItalyJ M Kane, E Aguglia, A C Altamura, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Journal of Neuroscience Research|May 8, 2000
Apoptosis induced by 2-chloro-adenosine and 2-chloro-2'-deoxy-adenosine in a human astrocytoma cell line: differential mechanisms and possible clinical relevanceS Ceruti, C Franceschi, D Barbieri, et al.
Pharmacological Reviews|June 10, 2018
International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological TargetsF Caraci, F Calabrese, R Molteni, et al.
Journal of Affective Disorders|June 5, 1999
Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistasN Brunello, H Akiskal, P Boyer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 9, 2000
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neurolepticsM Maes, L Bocchio Chiavetto, S Bignotti, et al.
Cardiovascular Diabetology|November 4, 2020
Depression and cardiovascular risk-association among Beck Depression Inventory, PCSK9 levels and insulin resistanceC Macchi, C Favero, A Ceresa, et al.
Molecular Psychiatry|February 19, 2014
Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortexG Treccani, L Musazzi, C Perego, et al.
Neuropsychobiology|October 3, 2000
Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatmentN Brunello, R Armitage, I Feinberg, et al.
The American Journal of Pathology|January 1, 1996
beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's diseaseG Giaccone, B Pedrotti, A Migheli, et al.
Journal of Affective Disorders|August 15, 2000
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatmentN Brunello, J A den Boer, L L Judd, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 7, 1998
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, ItalyJ M Kane, E Aguglia, A C Altamura, et al.
Pageof 17